Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Clive S. Grant is active.

Publication


Featured researches published by Clive S. Grant.


Journal of Clinical Oncology | 1999

Sentinel Lymph Node Biopsy With Metastasis: Can Axillary Dissection Be Avoided in Some Patients With Breast Cancer?

Carol Reynolds; Rosemarie Mick; John H. Donohue; Clive S. Grant; David R. Farley; Linda S. Callans; Susan G. Orel; Gary L. Keeney; Thomas J. Lawton; Brian J. Czerniecki

PURPOSE Recent studies have suggested that the sentinel lymph node (SLN) biopsy is an accurate alternative staging procedure for women with breast cancer. The goal of this study was to identify a subset of breast cancer patients in whom metastatic disease was confined only to the SLN. MATERIALS AND METHODS From two institutions, we recruited 222 women with breast cancer for SLN biopsy. A SLN biopsy was performed in each patient, followed by an axillary dissection in 182 patients. Histologic and immunohistochemical cytokeratin stains were used on all SLNs. RESULTS The SLN was identified in 220 (97. 8%) of the 225 biopsies. Evidence of metastatic breast cancer in the SLN was found in 60 (27.0%) of the 222 patients. Of these patients, 32 (53.3%) had evidence of tumor in the SLN only. By multivariate analysis, two factors were found to be significantly associated with a higher likelihood of tumor involvement in the non-SLNs: primary tumor size larger than 2.0 cm (P =.0004) and macrometastasis (> 2.0 mm) in the SLN (P =.002). Additional analysis revealed that none (0%; 95% confidence interval, 0% to 18.5%) of the 18 patients with primary tumors < or = 2.0 cm and micrometastasis to the SLN had remaining axillary lymph node involvement. CONCLUSION The primary tumor size and metastasis size in the SLN are independent factors in predicting the incidence of tumor in the non-SLNs. Therefore, the SLN biopsy alone may be adequate for staging and/or therapy decision making in patients with primary breast tumors < or = 2.0 cm and micrometastasis in the SLN.


Mayo Clinic Proceedings | 1992

Medullary Thyroid Carcinoma: Clinicopathologic Features and Long-Term Follow-Up of 65 Patients Treated During 1946 Through 1970

Hossein Gharib; William M. McConahey; Robert D. Tiegs; Erik J. Bergstralh; John R. Goellner; Clive S. Grant; Jon A. van Heerden; Glen W. Sizemore; Ian D. Hay

We retrospectively reviewed the medical records of 65 consecutive patients with medullary thyroid carcinoma, who had had their primary surgical treatment at the Mayo Clinic during the years 1946 through 1970. Of these patients, 58 had sporadic and 7 had familial medullary thyroid carcinoma. Thyroid nodules were the most common initial manifestation. Near-total thyroidectomy was the most frequent initial operation. Survival was affected by the following factors: male sex, familial inheritance, size of the tumor, stage of the tumor (American Joint Committee on Cancer), and completeness of initial resection of the tumor. The mean duration of follow-up was 23.5 years, and the maximal follow-up was 36 years. Among 52 patients without initial distant metastatic involvement and with complete resection of the tumor, 20-year survival free of distant metastatic lesions was 81%. Overall 10- and 20-year survival rates were 63% and 44%, respectively. Because of the substantial morbidity and mortality associated with medullary thyroid carcinoma, early diagnosis and thorough initial resection of the tumor are important.


Mayo Clinic Proceedings | 1992

Laparoscopic Cholecystectomy: Early Mayo Clinic Experience

John H. Donohue; Michael B. Farnell; Clive S. Grant; Jon A. van Heerden; H. Erik Wahlstrom; Michael G. Sarr; Amy L. Weaver; Duane M. Ilstrup

Prospective data and follow-up information were collected on the initial 200 patients who underwent laparoscopic cholecystectomy at the Mayo Clinic. The operation was completed laparoscopically in all but five patients, who required conversion to laparotomy because of dense scarring or stones in the common bile duct. The median surgical time was 85 minutes. The major postoperative complications were retained stones in the common bile duct (in seven patients), intraperitoneal hemorrhage that necessitated transfusion (in two patients), and intra-abdominal abscess and pulmonary infection (in one patient each). The median hospital stay was 1 day (range, 0 to 8 days), and the median times to full activity and normal employment were 8 days and 12 days, respectively. Laparoscopic cholecystectomy is associated with a low frequency of complications in most patients with symptomatic gallstones and allows a rapid return to normal activity. Currently, laparoscopic cholecystectomy is the treatment of choice for most patients with symptomatic cholelithiasis.


Mayo Clinic Proceedings | 1992

Laparoscopic Cholecystectomy: Operative Technique

John H. Donohue; Clive S. Grant; Michael B. Farnell; Jon A. van Heerden

Laparoscopic cholecystectomy has become the routine procedure for most patients with symptomatic cholelithiasis. At our institution, a two-surgeon, four-cannula technique is used. In almost all patients, a pneumoperitoneum can be established with use of a closed technique. Adherence to standard operative principles and careful attention to details in the laparoscopic technique will routinely result in the safe completion of laparoscopic cholecystectomy. Cautery provides excellent hemostasis during dissection of the gallbladder from its attachments. Cholangiography through the gallbladder or the cystic duct is easily performed in selected patients. Minimal perioperative care is necessary for patients who undergo laparoscopic cholecystectomy, and the hospitalization time is usually less than 24 hours.


Mayo Clinic Proceedings | 1991

Are Concomitant Surgical Procedures Acceptable in Patients Undergoing Cervical Exploration for Primary Hyperparathyroidism

David R. Farley; Jon A. van Heerden; Clive S. Grant

Cervical exploration for primary hyperparathyroidism is an extremely safe procedure with essentially no operative mortality or morbidity and with success rates approaching 98%. These results have encouraged experienced surgeons to perform other surgical procedures concomitantly with cervical exploration with use of the same general anesthetic agent. This retrospective study was performed to assess the safety and efficacy of this practice. At our institution, 117 patients underwent cervical exploration for primary hyperparathyroidism in combination with an additional surgical procedure, including breast (25), biliary (21), gynecologic (19), intra-abdominal (18), and cardiothoracic (6) operations. The mean operative time was 155 minutes, and the mean duration of hospitalization was 7.6 days. Postoperatively, 115 patients (98%) were normocalcemic. Nine complications (mostly minor), which occurred in eight patients, related primarily to the concomitant surgical procedure. No operative mortality occurred. If performed by experienced surgeons in carefully selected patients, cervical exploration for primary hyperparathyroidism in combination with another elective operation is safe and cost-effective.


Archive | 2005

THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND THE AMERICAN ASSOCIATION OF ENDOCRINE SURGEONS POSITION STATEMENT ON THE DIAGNOSIS AND MANAGEMENT OF PRIMARY HYPERPARATHYROIDISM

John S. Kukora; Martha A. Zeiger; Orlo H. Clark; Clive S. Grant; Stephen F. Hodgson; L. Irvin; Janice L. Pasieka; R. Shaha; Geoffrey B. Thompson; Jon A. van Heerden; Collin J. Weber


Archive | 2016

On White-Coat Effects and the Electronic Monitoring of Compliance

Clive S. Grant; John R. Goellner


Archive | 2013

Mol Fingerprint Thy Ca Cell Lines suppl data JCEM 95 5338 2010

Laura A. Marlow; Jaclyn D'Innocenzi; Yilin Zhang; Stephen D. Rohl; Simon J. Cooper; Thomas J. Sebo; Clive S. Grant; Bryan McIver; Jan L. Kasperbauer; J. Trad Wadsworth; John D. Casler; Pamela W. Kennedy; W. Edward Highsmith; Orlo H. Clark; Dragana Milosevic; Brian C. Netzel; Kendall W. Cradic; Shilpi Arora; Christian Beaudry; Stefan K. Grebe; Marc L. Silverberg; David O. Azorsa; Robert C. Smallridge; John A. Copland


Archive | 2013

Editorial Voice issues and laryngoscopy in thyroid surgery patients

Richard A. Hodin; Orlo H. Clark; Gerard M. Doherty; Clive S. Grant; Keith Heller; Ron Weigel


/data/revues/10727515/v213i1/S1072751511001876/ | 2011

Primary Aldosteronism: Results of Adrenalectomy for Nonsingle Adenoma

Amy R. Quillo; Clive S. Grant; Geoffrey B. Thompson; David R. Farley; Melanie L. Richards; William F. Young

Collaboration


Dive into the Clive S. Grant's collaboration.

Top Co-Authors

Avatar

John H. Donohue

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

David R. Farley

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge